Insider · CIK 0001371742

Ballantyne Charles Evan

Reports to the SEC for 4 companies · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001371742

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-10	GANXGain Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2023-04-10	GANXGain Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2016-06-14	AGENAGENUS INC · Restricted Stock UnitA Award	CFO	AAward	+14K sh	—	—	14,000
2016-06-14	AGENAGENUS INC · Stock Option, right to buyA Award	CFO	AAward	+75K sh	$4.16	+$312K	75,000
2016-04-26	AGENAGENUS INCA Award	CFO	AAward	+21.9K sh	$4.15	+$90.9K	31,902
2016-04-26	AGENAGENUS INCA Award	CFO	AAward	+21.7K sh	$4.15	+$90K	21,683
2016-04-26	AGENAGENUS INCD Disposition to Issuer	CFO	DDisposition to Issuer	−7,035 sh	$4.15	−$29.2K	14,648
2016-04-26	AGENAGENUS INCD Disposition to Issuer	CFO	DDisposition to Issuer	−7,107 sh	$4.15	−$29.5K	24,795
2015-09-25	AGENAGENUS INCP Purchase	CFO	PPurchase	+10K sh	$5.05	+$50.5K	10,000
2015-06-17	AGENAGENUS INC · Stock Option, right to buyA Award	CFO	AAward	+150K sh	$9.78	+$1.47M	150,000
2015-01-08	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, CFO	DDisposition to Issuer	−75K sh	$11.61	−$871K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, CFO	DDisposition to Issuer	−75K sh	$13.46	−$1.01M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, CFO	DDisposition to Issuer	−75K sh	$21.50	−$1.61M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, CFO	DDisposition to Issuer	−45K sh	$15.01	−$675K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, CFO	DDisposition to Issuer	−50K sh	$13.05	−$653K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, CFO	DDisposition to Issuer	−65K sh	$21.22	−$1.38M	0
2011-04-12	CLINICAL DATA INCU Disposition from Tender	EVP, CFO	UDisposition from Tender	−5,600 sh	$30.00	−$168K	0
2010-12-22	CLINICAL DATA INCStock Option (Right to Buy)A Award	EVP, CFO	AAward	+75K sh	—	—	75,000
2009-12-21	CLINICAL DATA INCStock Option (Right to Buy)A Award	EVP, CFO	AAward	+75K sh	—	—	75,000
2008-12-22	CLINICAL DATA INCStock Option (Right to Buy)A Award	EVP, CFO	AAward	+65K sh	—	—	65,000
2007-06-14	CLINICAL DATA INCStock Option (Right to buy)A Award	EVP, CFO	AAward	+30K sh	—	—	30,000
2006-08-21	CLINICAL DATA INCP Purchase	EVP, CFO	PPurchase	+400 sh	$12.46	+$4,984	400

Recent filings

Accepted (ET)
Apr 124
Ballantyne Charles Evan0001209191-23-024125
SEC(opens sec.gov)
Jun 164
AGENUS INC0001288123-16-000083
SEC(opens sec.gov)
May 134/A
AGENUS INC0001288123-16-000071
SEC(opens sec.gov)
Apr 284
AGENUS INC0001288123-16-000063
SEC(opens sec.gov)
Sep 294
AGENUS INC0001288123-15-000039
SEC(opens sec.gov)
Jun 174
AGENUS INC0001288123-15-000022
SEC(opens sec.gov)
Jan 124
Synthetic Biologics, Inc.0001144204-15-001702
SEC(opens sec.gov)
Apr 144
Ballantyne Charles Evan0001209191-11-022907
SEC(opens sec.gov)
Dec 234
Ballantyne Charles Evan0001209191-10-062435
SEC(opens sec.gov)
Dec 224
Ballantyne Charles Evan0001209191-09-058284
SEC(opens sec.gov)

Companies

Address

C/O CLINICAL DATA, INC. ONE GATEWAY CENTER, SUITE 702

NEWTON, MA, 02458